Novartis's new marker-gene system targets genetically modified crops
Article Abstract:
Novartis introduces a new marker-gene system that it hopes will quell farmers' fears of transgenic plants. The company intends to distribute the product among farmers in developing countries for free.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Novartis unveils restructuring of its main drug division
Article Abstract:
Novartis AG has revealed the restructuring plan of its flagship drug division. The restructuring is intended to increase the company's marketing power before the launch of several new drugs.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Novartis 11% profit increase, full-year results beat expectations
Article Abstract:
Novartis AG posted an improvement of 11% in its profits for the 1999 year. The company posted 3.68 billion Swiss francs (2.29 billion euros) in pretax profits for the year.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: World Online 's founder admits link to five failed companies. World Online plans give-back offer for worker shares
- Abstracts: Caterpillar's net in fourth quarter beats Wall Street estimates. Caterpillar net jumps 26%, tops analyst forecasts
- Abstracts: Spain's Santander, Abbey National of U.K. poised for $15 billion deal . Standard Chartered bids to buy Grindlays for $1.6 billion
- Abstracts: The top air cargo carriers: new services make the difference. Luxury consumers like it different
- Abstracts: Fenosa is given the green light to take over rival Cantabrico. Shareholders reject Fenosa's offer to buy Cantabrico